PATH-15. IDENTIFICATION OF SUBSETS OF IDH-MUTANT GLIOBLASTOMAS WITH DISTINCT EPIGENETIC AND COPY NUMBER ALTERATIONS AND STRATIFIED CLINICAL RISKS

類似資料

• Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks
  著者:: Li, Kay Ka-Wai, 等
  出版事項: (2019)
• PATH-42. IDH-MUTANT LOWER-GRADE ASTROCYTOMAS CAN BE STRATIFIED FOR RISK BY CDKN2A, CDK4 AND PDGFRA COPY NUMBER ALTERATIONS
  著者:: Rui Yang, Ryan, 等
  出版事項: (2019)
• Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification
  著者:: Keung Ng, Ho, 等
  出版事項: (2019)
• PATH-02. A COMBINATION OF MGMT METHYLATION AND NFKBIA COPY NUMBER ALTERATION REFINES PROGNOSTICATION OF IDH-WT GLIOBLASTOMAS
  著者:: Umehara, Toru, 等
  出版事項: (2019)
• PATH-23. GENOMIC LANDSCAPE OF IDH-MUTANT PRIMARY GLIOBLASTOMAS SHOWS DISTINCT CLINICAL AND MOLECULAR FEATURES AND THAT CDKN2A SHOULD BE SUPPLEMENTED WITH MGMTp AND G-CIMP FOR PRECISE PROGNOSTICATION
  著者:: Wong, Queenie Hoi-Wing, 等
  出版事項: (2020)